Enovix CEO RSU tax withholding of 17,650 shares

Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition tied to equity compensation.

Rhea-AI Filing Summary

Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition tied to equity compensation. On the reported date, 17,650 shares of common stock were withheld at $7.08 per share to cover tax obligations arising from vesting restricted stock units.

After this withholding, Talluri directly owned 3,044,616 shares of Enovix common stock. This total includes 1,956,490 shares issuable upon future vesting and settlement of RSUs, 47,775 vested performance RSUs scheduled for release in March 2027, and 259,611 additional PRSUs with releases in April 2027 and April 2028.

Insider Trade Summary

Exercise Price or Tax Liability: 17,650 shares

Exercise Price or Tax Liability 1 txn

Insider Talluri Rajendra K

Role President and CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	17,650	$7.08	$125K

Holdings After Transaction: Common Stock — 3,044,616 shares (Direct)

Footnotes (2)

1. F1. Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
2. F2. Includes 1,956,490 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person, as well as: (i) 47,775 vested performance restricted stock units ("PRSUs"), which will be released to the Reporting Person in March 2027, and (ii) an aggregate of 259,611 PRSUs, 50% of which will be released in April 2027, with the remainder to be released in April 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Key Figures

Shares withheld for taxes: 17,650 shares Withholding price: $7.08 per share Shares after transaction: 3,044,616 shares +3 more

6 metrics

Shares withheld for taxes 17,650 shares Tax withholding disposition at $7.08 per share on common stock

Withholding price $7.08 per share Value used for tax-withholding disposition of 17,650 shares

Shares after transaction 3,044,616 shares Total Enovix common shares directly owned following the transaction

RSUs issuable 1,956,490 shares Shares issuable upon vesting and settlement of RSUs granted to the CEO

Vested PRSUs 47,775 units Vested performance RSUs to be released in March 2027

Additional PRSUs 259,611 units Performance RSUs to be released 50% in April 2027 and 50% in April 2028

Key Terms

restricted stock units ("RSUs"), performance restricted stock units ("PRSUs"), tax withholding obligations, vesting and settlement

4 terms

restricted stock units ("RSUs") financial

"Reflects the withholding of shares ... in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

performance restricted stock units ("PRSUs") financial

"Includes 1,956,490 shares issuable ... and (i) 47,775 vested performance restricted stock units ("PRSUs")."

tax withholding obligations financial

"Reflects the withholding of shares ... to satisfy tax withholding obligations in connection with the vesting of RSUs."

vesting and settlement financial

"Includes 1,956,490 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Enovix (ENVX) CEO Rajendra Talluri report in this Form 4?

The CEO reported a tax-withholding disposition of 17,650 shares of Enovix common stock. These shares were withheld to satisfy tax obligations triggered by the vesting of restricted stock units (RSUs), rather than being sold in an open-market transaction.

Was the Enovix (ENVX) CEO’s Form 4 transaction an open-market sale?

No. The Form 4 describes a tax-withholding disposition, not an open-market sale. Shares were withheld by the company to cover tax liabilities from RSU vesting, a common administrative step in equity compensation, rather than a discretionary sale by the CEO.

How many Enovix (ENVX) shares were involved in the CEO’s tax withholding?

The filing shows 17,650 shares of Enovix common stock were withheld at $7.08 per share. This withholding satisfied tax obligations associated with the vesting of restricted stock units granted to President and CEO Rajendra K. Talluri.

How many Enovix (ENVX) shares does the CEO hold after this Form 4 event?

After the transaction, the CEO directly held 3,044,616 shares of Enovix common stock. This figure includes RSUs and performance RSUs that will settle into shares upon future vesting and scheduled release dates extending into 2027 and 2028.

What future RSU and PRSU releases are disclosed for the Enovix (ENVX) CEO?

The filing notes 1,956,490 RSU shares issuable upon vesting and settlement, plus 47,775 vested PRSUs releasing in March 2027 and 259,611 PRSUs, half releasing in April 2027 and the remainder in April 2028, each representing one common share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 06:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Talluri Rajendra K

(Last) (First) (Middle)

C/O ENOVIX CORPORATION

3501 W. WARREN AVENUE

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2026		F		17,650(1)	D	$7.08	3,044,616(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

2. Includes 1,956,490 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person, as well as: (i) 47,775 vested performance restricted stock units ("PRSUs"), which will be released to the Reporting Person in March 2027, and (ii) an aggregate of 259,611 PRSUs, 50% of which will be released in April 2027, with the remainder to be released in April 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for Raj Talluri	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)